We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
SUBSCRIBE: eNewsletter
 REM Sleep Behavior Disorder Predicts Neurodegeneration RiskApr 24, 2018 The presence of REM Behavior Disorder predicted an increased risk of Parkinson disease, Lewy Body dementia, or multisystem atrophy in the largest study ever performed in people with the strange disorder. Details here. |
 Midlife Cardiovascular Fitness and Dementia in WomenApr 23, 2018 It looks like research is starting to support exercise as a reliable strategy to prevent dementia. |
 Parkinson vs Alzheimer Dementia: A Clinical SignApr 23, 2018 The finger displacement sign is a simple bedside test that can help distinguish Parkinson dementia from Alzheimer dementia. |
 In Vivo Biomarkers for Chronic Traumatic EncephalopathyApr 20, 2018 Chronic traumatic encephalopathy is a neurodegenerative disease that is believed to be a consequence of exposure to repetitive head impacts, including concussions and subconcussive injuries. |
 CGRPs: New Help in Migraine Prophylaxis?Apr 20, 2018 A new class of injectable monoclonal antibodies directed against calcitonin gene related peptide (CGRP) or its receptor may offer hope to migraineurs who have not found effective prophylactic therapy. |
 Mini Quiz: Beers CriteriaDisplay date: Apr 19, 2018When and why were the Beers criteria set in place? Learn more in this quiz. |
 6 New Drugs for NeurologistsApr 18, 2018 Newly approved medications for various types of pain, generalized myasthenia gravis, and Parkinson disease will be fodder for discussion at AAN 2018. Here’s a brief overview of the therapies the FDA has approved within the past 6 months. |
 Ondine's Curse: Causes, Symptoms, and TreatmentApr 17, 2018 Ondine’s curse has long been recognized as a congenital disorder and can also develop later in life as a result of damage to the lower lateral medulla. There are only a few cases—about 200 to 500 worldwide—each year. |
 Neuro-Ophthalmologic Disorders: Issues in Diagnosis and TreatmentApr 16, 2018 Neurologists may be the first or only clinicians to recognize the 5 potentially dangerous neuro-ophthalmologic conditions described in this article. |
 Sodium Valproate Linked to Lower School Test ScoresApr 12, 2018 Findings from a new study indicate that compared with children who were not exposed to the drug, children with in utero exposure to sodium valproate have lower scores on national tests at age 7 years. |
